These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12500906)

  • 21. The poisoning of 'awa: the non-traditional use of an ancient remedy.
    O'Sullivan HM; Lum K
    Pac Health Dialog; 2004 Sep; 11(2):211-5. PubMed ID: 16281702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).
    Johnson BM; Qiu SX; Zhang S; Zhang F; Burdette JE; Yu L; Bolton JL; van Breemen RB
    Chem Res Toxicol; 2003 Jun; 16(6):733-40. PubMed ID: 12807356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sale of kava extract in some health food stores.
    Mills E; Singh R; Ross C; Ernst E; Ray JG
    CMAJ; 2003 Nov; 169(11):1158-9. PubMed ID: 14638649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?
    Currie BJ; Clough AR
    Med J Aust; 2003 May; 178(9):421-2. PubMed ID: 12720503
    [No Abstract]   [Full Text] [Related]  

  • 25. Kava-induced fulminant hepatic failure.
    Campo JV; McNabb J; Perel JM; Mazariegos GV; Hasegawa SL; Reyes J
    J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):631-2. PubMed ID: 12049436
    [No Abstract]   [Full Text] [Related]  

  • 26. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
    Teschke R
    Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kava as a Clinical Nutrient: Promises and Challenges.
    Bian T; Corral P; Wang Y; Botello J; Kingston R; Daniels T; Salloum RG; Johnston E; Huo Z; Lu J; Liu AC; Xing C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dangerous dietary supplements:
    Lunsford KE; Bodzin AS; Reino DC; Wang HL; Busuttil RW
    World J Gastroenterol; 2016 Dec; 22(45):10071-10076. PubMed ID: 28018115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic hepatitis after consumption of traditional kava preparation.
    Christl SU; Seifert A; Seeler D
    J Travel Med; 2009; 16(1):55-6. PubMed ID: 19192130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kava--the unfolding story: report on a work-in-progress.
    Denham A; McIntyre M; Whitehouse J
    J Altern Complement Med; 2002 Jun; 8(3):237-63. PubMed ID: 12165183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal and Dietary Supplement-Induced Liver Injury.
    de Boer YS; Sherker AH
    Clin Liver Dis; 2017 Feb; 21(1):135-149. PubMed ID: 27842768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of federal safety advisories on health food store advice.
    Mills E; Singh R; Ross C; Ernst E; Wilson K
    J Gen Intern Med; 2004 Mar; 19(3):269-72. PubMed ID: 15009783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are dietary supplements safe?
    Kam RY
    HDA Now; 2013; ():18-9. PubMed ID: 24427969
    [No Abstract]   [Full Text] [Related]  

  • 34. The curious case of Kava.
    Grossman L
    Time; 2002 Apr; 159(14):58. PubMed ID: 11951318
    [No Abstract]   [Full Text] [Related]  

  • 35. Kava Hepatotoxicity: Are we any closer to the truth?
    Anke J; Ramzan I
    Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sebotropic eruption associated with use of oral kava kava supplement.
    Huynh JC; Asgari MM; Moore MM
    Clin Exp Dermatol; 2014 Oct; 39(7):816-8. PubMed ID: 25214405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
    Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
    J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal fulminant hepatic failure induced by a natural therapy containing kava.
    Gow PJ; Connelly NJ; Hill RL; Crowley P; Angus PW
    Med J Aust; 2003 May; 178(9):442-3. PubMed ID: 12720510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats.
    Lim ST; Dragull K; Tang CS; Bittenbender HC; Efird JT; Nerurkar PV
    Toxicol Sci; 2007 May; 97(1):214-21. PubMed ID: 17329236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.